Viatris Inc (NASDAQ:VTRS)

9.68
Delayed Data
As of 4:00pm ET
 +0.31 / +3.31%
Today’s Change
8.74
Today|||52-Week Range
12.40
-13.03%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$11.2B

Company Description

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Contact Information

Viatris, Inc.
Robert J. Coury Global Center
Canonsburg Pennsylvania 15317
P:(724) 514-1800
Investor Relations:
(724) 514-1813

Employees

Shareholders

Mutual fund holders45.93%
Other institutional32.83%
Individual stakeholders0.33%

Top Executives

Scott Andrew SmithChief Executive Officer & Director
Rajiv MalikPresident & Director
Sanjeev Kumar SethiChief Operating Officer
Sanjeev NarulaChief Financial Officer
Ramkumar V. RayapureddyChief Information Officer